CLINICAL TRIALS PROFILE FOR OLMESARTAN MEDOXOMIL
✉ Email this page to a colleague
All Clinical Trials for OLMESARTAN MEDOXOMIL
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00134160 ↗ | OlmeSartan and Calcium Antagonists Randomized (OSCAR) Study | Completed | Japan Heart Foundation | Phase 4 | 2005-08-01 | The purpose of this study is to investigate whether high-dose angiotensin II receptor blocker (ARB) monotherapy or combination therapy with ARB and calcium channel blockers is more effective in reducing the incidence of cardiovascular events in Japanese elderly high-risk hypertensive patients not adequately controlled by standard dose ARB alone. |
NCT00134160 ↗ | OlmeSartan and Calcium Antagonists Randomized (OSCAR) Study | Completed | OSCAR Study | Phase 4 | 2005-08-01 | The purpose of this study is to investigate whether high-dose angiotensin II receptor blocker (ARB) monotherapy or combination therapy with ARB and calcium channel blockers is more effective in reducing the incidence of cardiovascular events in Japanese elderly high-risk hypertensive patients not adequately controlled by standard dose ARB alone. |
NCT00139698 ↗ | Olmesartan Alone or in Combination With Hydrochlorothiazide in Subjects With Mild to Moderate Essential Hypertension | Completed | Pfizer | Phase 3 | 2005-09-01 | Efficacy, tolerability and safety of olmesartan alone or in combination with hydrochlorothiazide in the treatment of mild to moderate essential hypertension |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for OLMESARTAN MEDOXOMIL
Condition Name
Clinical Trial Locations for OLMESARTAN MEDOXOMIL
Trials by Country
Clinical Trial Progress for OLMESARTAN MEDOXOMIL
Clinical Trial Phase
Clinical Trial Sponsors for OLMESARTAN MEDOXOMIL
Sponsor Name